Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Primary small cell carcinoma of the esophagus: review of 64 cases from a single institution.

Zhu Y, Qiu B, Liu H, Li Q, Xiao W, Hu Y, Liu M.

Dis Esophagus. 2014 Feb-Mar;27(2):152-8. doi: 10.1111/dote.12069. Epub 2013 May 3.

PMID:
23639106
2.

[Clinical analysis of 126 patients with primary small cell carcinoma of the esophagus].

Lü JM, Liang J, Wang JW, He J, Xiao ZF, Zhang HX, Chen DF, Feng QF, Wang LH.

Zhonghua Zhong Liu Za Zhi. 2009 Feb;31(2):121-5. Chinese.

PMID:
19538888
3.

Role of surgery in the management and prognosis of limited-stage small cell carcinoma of the esophagus.

Xie MR, Xu SB, Sun XH, Ke L, Mei XY, Liu CQ, Ma DC.

Dis Esophagus. 2015 Jul;28(5):476-82. doi: 10.1111/dote.12230. Epub 2014 May 2.

PMID:
24787553
4.

Treatment and prognosis of limited disease primary small cell carcinoma of esophagus.

Chen SB, Yang JS, Yang WP, Weng HR, Li H, Liu DT, Chen YP.

Dis Esophagus. 2011 Feb;24(2):114-9. doi: 10.1111/j.1442-2050.2010.01112.x. Epub 2010 Oct 11.

PMID:
21040151
5.

[Surgical treatment and prognostic analysis of 109 patients with primary esophageal small cell carcinoma].

Zhang BH, Yang WJ, Zhao L, He J, Wang YG, Zhang HT.

Zhonghua Zhong Liu Za Zhi. 2012 Sep;34(9):698-702. doi: 10.3760/cma.j.issn.0253-3766.2012.09.012. Chinese.

PMID:
23159085
6.

Primary small cell carcinoma of the esophagus.

Lv J, Liang J, Wang J, Wang L, He J, Xiao Z, Yin W.

J Thorac Oncol. 2008 Dec;3(12):1460-5. doi: 10.1097/JTO.0b013e31818e1247.

7.

A retrospective study of different treatments of limited-stage small-cell esophageal carcinoma and associated prognostic factor analysis.

Ding J, Ji J, Zhu W, Zhou K, Han J, Zhang Y, Yu C, Li T, Tao G, Ji F, Zhou X, Pan P.

Dis Esophagus. 2013 Sep-Oct;26(7):696-702. doi: 10.1111/dote.12017. Epub 2013 Jan 14.

PMID:
23317069
8.

Detailed analysis of prognostic factors in primary esophageal small cell carcinoma.

Chen WW, Wang F, Chen S, Wang L, Ren C, Luo HY, Wang FH, Li YH, Zhang DS, Xu RH.

Ann Thorac Surg. 2014 Jun;97(6):1975-81. doi: 10.1016/j.athoracsur.2014.02.037. Epub 2014 Apr 14.

PMID:
24726599
9.

[Clinical analysis of 33 cases of primary esophageal small cell carcinoma].

Duan HB, Wu HY, Su XD, Zeng CG, Dai WQ, Huang L.

Ai Zheng. 2007 Jul;26(7):771-4. Chinese.

PMID:
17626757
10.

The 2002 AJCC TNM classification is a better predictor of primary small cell esophageal carcinoma outcome than the VALSG staging system.

Wang SY, Mao WM, Du XH, Xu YP, Zhang SZ.

Chin J Cancer. 2013 Jun;32(6):342-52. doi: 10.5732/cjc.012.10161. Epub 2012 Oct 10.

11.

Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.

Shridhar R, Freilich J, Hoffe SE, Almhanna K, Fulp WJ, Yue B, Karl RC, Meredith K.

Ann Surg Oncol. 2014 Nov;21(12):3744-50. doi: 10.1245/s10434-014-3795-2. Epub 2014 May 23.

PMID:
24854492
12.

Primary mucoepidermoid carcinoma of the esophagus.

Chen S, Chen Y, Yang J, Yang W, Weng H, Li H, Liu D.

J Thorac Oncol. 2011 Aug;6(8):1426-31. doi: 10.1097/JTO.0b013e31821cfb96.

13.

Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma.

Rice TW, Adelstein DJ, Chidel MA, Rybicki LA, DeCamp MM, Murthy SC, Blackstone EH.

J Thorac Cardiovasc Surg. 2003 Nov;126(5):1590-6.

14.

Management of locoregional stage esophageal cancer: a single center experience.

Javle MM, Nwogu CE, Donohue KA, Iyer RV, Brady WE, Khemka SV, Smith JL, Demmy TL, Yang GY, Nava HR.

Dis Esophagus. 2006;19(2):78-83.

PMID:
16643174
15.

[Analysis of prognostic factors in patients with locoregional recurrence of esophageal carcinoma after curative treatment].

Xu YP, Mao WM, Ma SL, Jiang YH, Liu JS, Sun XJ.

Zhonghua Zhong Liu Za Zhi. 2011 Dec;33(12):925-8. Chinese.

PMID:
22340103
16.

[Clinical analysis of 81 cases with primary small cell carcinoma of the esophagus].

Zhan XK, Sun YK, Zhang W, Wang JW.

Zhonghua Zhong Liu Za Zhi. 2008 Dec;30(12):926-9. Chinese.

PMID:
19173995
17.

Cervical esophageal cancer: a population-based study.

Grass GD, Cooper SL, Armeson K, Garrett-Mayer E, Sharma A.

Head Neck. 2015 Jun;37(6):808-14. doi: 10.1002/hed.23678. Epub 2014 Jun 19.

PMID:
24616217
18.

Prognostic analysis of the patients with stage-III esophageal squamous cell carcinoma after radical esophagectomy.

Hu Y, Zheng B, Rong TH, Fu JH, Zhu ZH, Yang H, Luo KJ, Li YF.

Chin J Cancer. 2010 Feb;29(2):178-83.

19.

A reliable risk score for stage IV esophagogastric cancer.

Blank S, Lordick F, Dobritz M, Grenacher L, Burian M, Langer R, Roth W, Schaible A, Becker K, Bläker H, Sisic L, Stange A, Compani P, Schulze-Bergkamen H, Jäger D, Büchler M, Siewert JR, Ott K.

Eur J Surg Oncol. 2013 Aug;39(8):823-30. doi: 10.1016/j.ejso.2013.01.005. Epub 2013 Jan 31.

PMID:
23375470
20.

Incurable esophageal cancer: patterns of tumor spread and therapeutic consequences.

Gockel I, Kneist W, Junginger T.

World J Surg. 2006 Feb;30(2):183-90.

PMID:
16425075

Supplemental Content

Support Center